Otorhinolaryngological manifestations of coronavirus disease 2019: a prospective review of 600 patients
- PMID: 33455587
- PMCID: PMC7925986
- DOI: 10.1017/S0022215121000220
Otorhinolaryngological manifestations of coronavirus disease 2019: a prospective review of 600 patients
Abstract
Objectives: To evaluate otorhinolaryngological manifestations of coronavirus disease 2019 infection and the time required for their resolution.
Methods: A prospective analysis was conducted of coronavirus disease 2019 patients presenting from 1 April 2020 to 30 July 2020. The otorhinolaryngological manifestations were evaluated based on patient history. The time required for symptom resolution was evaluated separately for intensive care unit and non-intensive care unit patients.
Results: A total of 600 patients were included in the study; 13.3 per cent required the intensive care unit and 2.2 per cent expired. The otorhinolaryngological manifestations were: sore throat (88 per cent), fever (78.8 per cent), anosmia or hyposmia (63.6 per cent), ageusia or hypogeusia (63.5 per cent), rhinorrhoea (51.3 per cent), nasal obstruction (33.5 per cent), sneezing (30.3 per cent), and breathing difficulty (18.6 per cent). The time required for symptom resolution was longest for breathing difficulty (23.6 days for intensive care unit and 8.2 days for non-intensive care unit patients).
Conclusion: Otorhinolaryngological symptoms are one of the main presentations of coronavirus disease 2019 infection. The increased prevalence of medical co-morbidities in patients requiring intensive care unit and in deceased patients is also highlighted.
Keywords: COVID-19; Comorbidity; Prospective Studies.
Conflict of interest statement
None declared
Figures




Similar articles
-
COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.Auris Nasus Larynx. 2021 Dec;48(6):1176-1180. doi: 10.1016/j.anl.2021.05.010. Epub 2021 Jun 9. Auris Nasus Larynx. 2021. PMID: 34172351 Free PMC article.
-
Anosmia in the first coronavirus disease 2019 outbreak in Europe: functional recovery after eight months.J Laryngol Otol. 2021 Mar;135(3):224-228. doi: 10.1017/S0022215121000670. Epub 2021 Feb 26. J Laryngol Otol. 2021. PMID: 33632353 Free PMC article.
-
Otorhinolaryngological problems occurring within the intensive care unit.Intensive Care Med. 2003 Jun;29(6):884-889. doi: 10.1007/s00134-003-1764-5. Epub 2003 Apr 24. Intensive Care Med. 2003. PMID: 12712242 Review.
-
Dysphagia incidence in intensive care unit patients with coronavirus disease 2019: retrospective analysis following systematic dysphagia screening.J Laryngol Otol. 2022 Dec;136(12):1278-1283. doi: 10.1017/S0022215122001517. Epub 2022 Jun 22. J Laryngol Otol. 2022. PMID: 35730238
-
Ear, nose, and throat manifestations of COVID-19 and its vaccines.World J Clin Cases. 2022 Sep 6;10(25):8808-8815. doi: 10.12998/wjcc.v10.i25.8808. World J Clin Cases. 2022. PMID: 36157654 Free PMC article. Review.
Cited by
-
Study of Hearing Status in COVID-19 Patients: A Multicentered Review.Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3036-3042. doi: 10.1007/s12070-021-02710-w. Epub 2021 Jul 12. Indian J Otolaryngol Head Neck Surg. 2022. PMID: 34277385 Free PMC article.
-
Long-Term Outcomes of COVID-19 Otolaryngology Symptoms in Saudi Arabia.Cureus. 2023 Jan 6;15(1):e33461. doi: 10.7759/cureus.33461. eCollection 2023 Jan. Cureus. 2023. PMID: 36751176 Free PMC article.
-
Exploring the Clinical Utility of Gustatory Dysfunction (GD) as a Triage Symptom Prior to Reverse Transcription Polymerase Chain Reaction (RT-PCR) in the Diagnosis of COVID-19: A Meta-Analysis and Systematic Review.Life (Basel). 2021 Nov 29;11(12):1315. doi: 10.3390/life11121315. Life (Basel). 2021. PMID: 34947846 Free PMC article. Review.
-
Long-term upper aerodigestive sequelae as a result of infection with COVID-19.Laryngoscope Investig Otolaryngol. 2022 Mar 9;7(2):476-485. doi: 10.1002/lio2.763. eCollection 2022 Apr. Laryngoscope Investig Otolaryngol. 2022. PMID: 35434347 Free PMC article.
-
The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia.ACS Chem Neurosci. 2021 Oct 6;12(19):3535-3549. doi: 10.1021/acschemneuro.1c00542. Epub 2021 Sep 17. ACS Chem Neurosci. 2021. PMID: 34533304 Free PMC article.
References
-
- Wang M, Wu Q, Xu W, Qiao B, Wang J, Zheng H et al.. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. medRxiv 2020;2020.02.12.20022327
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous